Adalimumab Treatment Results in Deep Remission for Patients With Moderate to Severe Ileocolonic Crohn's Disease: Results From EXTEND

被引：0
|
作者：
Colombel, Jean-Frederic
Rutgeerts, Paul J.
Sandborn, William J.
Camez, Anne A.
Pollack, Paul F.
Chen, Naijun
Yang, Mei
Mulani, Parvez
Chao, Jingdong
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T1239
引用
收藏
页码：S518 / S518
页数：1
相关论文
共 50 条
  • [1] Sustained Mucosal Healing in Adalimumab-Treated patients with moderate to severe Ileocolonic Crohn's Disease: Results of the EXTEND Trial
    Rutgeerts, P.
    D'Haens, G.
    van Assche, G.
    Sandborn, W.
    Wolf, D.
    Colombel, J.
    Reinisch, W.
    Geboes, K.
    Khan, M.
    Lazar, A.
    Camez, A.
    Pollack, P.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S13 - S13
  • [2] Adalimumab Induces and Maintains Mucosal Healing in Patients with Moderate to Severe Ileocolonic Crohn's Disease - First Results of the Extend Trial
    Rutgeerts, Paul
    D'Haens, Geert R.
    Van Assche, Gert A.
    Sandborn, William J.
    Wolf, Douglas C.
    Colombel, Jean-Frederic
    Reinisch, Walter
    Geboes, Karel
    Khan, Mahmudul
    Lazar, Andreas
    Camez, Anne
    Pollack, Paul F.
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A116 - A116
  • [3] Economic Impact of Deep Remission in Adalimumab-Treated Patients With Crohn's Disease: Results From Extend
    Sandborn, William J.
    Colombel, Jean-Frederic
    Louis, Edouard
    Panaccione, Remo
    Yang, Mei
    Chao, Jingdong
    Mulani, Parvez
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S205 - S205
  • [4] Adalimumab Downregulates Markers of Inflammation in Patients with Moderate to Severe Ileocolonic Crohn's Disease: The Histologic Substudy of EXTEND
    Geboes, Karel
    Rutgeerts, Paul
    Camez, Anne
    Lazar, Andreas
    Lomax, Kathleen
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S431 - S431
  • [5] Work Productivity Improvements in Adalimumab-treated Patients with Moderate to Severe Ileocolonic Crohn's Disease: The EXTEND Trial
    Binion, David
    Rutgeerts, Paul
    van Assche, Gert
    Chen, Naijun
    Chao, Jingdong
    Mulani, Parvez
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S462 - S462
  • [6] Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial
    Panaccione, Remo
    Loftus, Edward V., Jr.
    Binion, David
    McHugh, Kevin
    Alam, Shamsul
    Chen, Naijun
    Guerette, Benoit
    Mulani, Parvez
    Chao, Jingdong
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY, 2011, 25 (08): : 419 - 425
  • [7] How effective is adalimumab for inducing remission in patients with moderate-to-severe Crohn's disease?
    Ghosh, Subrata
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (10): : 540 - 541
  • [8] How effective is adalimumab for inducing remission in patients with moderate-to-severe Crohn's disease?
    Subrata Ghosh
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 540 - 541
  • [9] Adalimumab Induces Deep Remission in Patients With Crohn's Disease
    Colombel, Jean-Frederic
    Rutgeerts, Paul J.
    Sandborn, William J.
    Yang, Mei
    Camez, Anne
    Pollack, Paul F.
    Thakkar, Roopal B.
    Robinson, Anne M.
    Chen, Naijun
    Mulani, Parvez M.
    Chao, Jingdong
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (03) : 414 - +
  • [10] Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease: Results From the CHARM Trial
    Colombel, Jean-Frederic
    Sandborn, William J.
    Rutgeerts, Paul
    Kamm, Michael A.
    Yu, Andrew P.
    Wu, Eric Q.
    Pollack, Paul F.
    Lomax, Kathleen G.
    Chao, Jingdong
    Mulani, Parvez M.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (05): : 1170 - 1179
12345